| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $2.7B | $2.4B | $3.4B | $2.6B | $1.1B | $1.6B | $1.1B |
| Cost of Revenue | — | — | — | — | — | — | $0.5B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.0B | $1.1B | $1.0B | $1.6B | $0.2B | $-1.1B | $-0.1B | $-0.2B |
| Net Income | $0.6B | $0.8B | $0.8B | $1.1B | $0.0B | $-0.8B | $-0.2B | $-0.2B |
| EPS (Basic) | $5.65 | $6.71 | $6.89 | $9.09 | $0.30 | $-6.72 | $-1.66 | $-1.44 |
| EPS (Diluted) | $5.64 | $6.67 | $6.86 | $8.96 | $0.29 | $-6.72 | $-1.66 | $-1.44 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.3B | $8.6B | $6.4B | $5.7B | $5.2B | $5.0B | $6.3B | $6.2B |
| Current Assets | $0.8B | $0.4B | $0.9B | $0.7B | $0.6B | $0.2B | $0.3B | $0.5B |
| Cash & Equivalents | $0.4B | $0.0B | $0.6B | $0.4B | $0.3B | $0.0B | $0.0B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.2B | $0.8B | $0.6B | $0.6B | $0.9B | $0.6B | $0.5B | $0.6B |
| Stockholders' Equity | $4.8B | $4.2B | $3.6B | $3.1B | $2.1B | $2.0B | $2.7B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $1.8B | $1.6B | $1.7B | $1.2B | $0.8B | $0.8B | $0.5B |
| Investing Cash Flow | $-1.5B | $-3.4B | $-1.1B | $-0.9B | $-0.7B | $-0.6B | $-1.0B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $1.0B | $-0.3B | $-0.7B | $-0.2B | $-0.2B | $0.1B | $-0.0B |